Lyra Therapeutics, Inc. (LYRA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:36AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 17.07M |
| Enterprise Value | -32.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.43 |
| Price/Book (mrq) | 0.22 |
| Enterprise Value/Revenue | -21.80 |
| Enterprise Value/EBITDA | 0.66 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.00 |
| 52-Week Change 3 | -92.43% |
| S&P500 52-Week Change 3 | 25.87% |
| 52 Week High 3 | 6.7900 |
| 52 Week Low 3 | 0.2530 |
| 50-Day Moving Average 3 | 1.1500 |
| 200-Day Moving Average 3 | 3.6864 |
Share Statistics
| Avg Vol (3 month) 3 | 3.88M |
| Avg Vol (10 day) 3 | 2.7M |
| Shares Outstanding 5 | 60.96M |
| Implied Shares Outstanding 6 | 60.96M |
| Float 8 | 37.65M |
| % Held by Insiders 1 | 0.70% |
| % Held by Institutions 1 | 88.11% |
| Shares Short (Jun 14, 2024) 4 | 1.55M |
| Short Ratio (Jun 14, 2024) 4 | 0.69 |
| Short % of Float (Jun 14, 2024) 4 | 3.23% |
| Short % of Shares Outstanding (Jun 14, 2024) 4 | 2.54% |
| Shares Short (prior month May 15, 2024) 4 | 603.03k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -4,421.81% |
Management Effectiveness
| Return on Assets (ttm) | -38.10% |
| Return on Equity (ttm) | -95.93% |
Income Statement
| Revenue (ttm) | 1.68M |
| Revenue Per Share (ttm) | 0.03 |
| Quarterly Revenue Growth (yoy) | 29.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -71.61M |
| Net Income Avi to Common (ttm) | -68.88M |
| Diluted EPS (ttm) | -1.1700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.12M |
| Total Cash Per Share (mrq) | 1.43 |
| Total Debt (mrq) | 37.86M |
| Total Debt/Equity (mrq) | 48.85% |
| Current Ratio (mrq) | 4.78 |
| Book Value Per Share (mrq) | 1.27 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -69.91M |
| Levered Free Cash Flow (ttm) | -39.69M |
© 2024 Yahoo. All rights reserved.